Skip to content
Men Under Microscope – Lifestyle
Author:
ONCOVITA
Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission
November 9, 2026
Oncovita presents promising preclinical data on MVdeltaC, a novel onco-immunotherapy at EACR, 8-11 June 2026, in Budapest
June 4, 2026